By Tom Steinert-Threlkeld  |  Posted 2003-05-01 Email Print this article Print

Endo Pharmaceuticals started out small. But it acted from the beginning as if it would be a billion-dollar company.

-Free in 2002">

Endo Pharmaceuticals: Pain-Free in 2002

Percocet manufacturer Endo Pharmaceuticals worried it might grow so fast, it installed SAP R/3 as its enterprise planning software, from its inception as an offshoot of a Dupont-Merck joint venture. Last year proved the case: The company raised its "guidance" on annual sales for the year three times. And its final estimate was still too low.

  • Sales of Percocet and Lidoderm pain drugs spur first revision of projected revenue.

  • Migration begins to fourth version of SAP customer management software.

  • Cash flow doubles; net loss reduced by 45%.

  • Still on tap: Linking Futurecast sales-forecasting software to SAP.

    Final sales for the year: $399M

    Projection raised one last time


    Projection raised again, to $350M


    Projection raised to $300M at start of Q2...



    Sales projected

    for full year:







    BASELINE Company's guidance to market on expected sales for the year, before each quarter started.

    ACTUAL Endo's sales, year to date.


  • <12345
    Tom was editor-in-chief of Interactive Week, from 1995 to 2000, leading a team that created the Internet industry's first newspaper and won numerous awards for the publication. He also has been an award-winning technology journalist for the Dallas Morning News and Fort Worth Star-Telegram. He is a graduate of the Harvard Business School and the University of Missouri School of Journalism.

    Submit a Comment

    Loading Comments...
    Manage your Newsletters: Login   Register My Newsletters